Muhammad Aqa Qablan Al-Harbi
Biographic Data
| ID | 9458020 |
|---|---|
| NAME | Muhammad Aqa Qablan Al-Harbi |
| GIVEN NAMES | Muhammad Aqa Qablan |
| FAMILY NAME | Al-Harbi |
| SIGNATURE | AL-HARBI M A Q |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
No prominent works on this page.
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Current Strategies for Improvements in the Treatment of Alzheimer's Disease
There have been many promising developments in recent years. Several new targets have been identified and new drugs developed, or existing drugs adapted, to treat AD. However, there are problems with side-effects and specificity. A number of drugs have reduced β-amyloid/ phosphorylated tau levels and improved cognitive function in animal models and in humans but then produced no significant benefit in AD patients in phase 3 trials. Several strate…
Dementia and Cognitive Impairment Research (2 works) · Disease (2 works) · Electrical engineering (2 works) · Engineering (2 works) · Health, Environment, Cognitive Aging (2 works) · Medicine (2 works) · Neuroscience (2 works) · Psychology (2 works) · Current (fluid (1 work) · Current (fluid) (1 work)